Palisade Bio Stock Market Value
| PALI Stock | USD 2.44 0.01 0.41% |
| Symbol | Palisade |
Palisade Bio Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.26) | Return On Assets (0.59) | Return On Equity (1.10) |
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Palisade Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Palisade Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Palisade Bio.
| 05/26/2024 |
| 11/22/2024 |
If you would invest 0.00 in Palisade Bio on May 26, 2024 and sell it all today you would earn a total of 0.00 from holding Palisade Bio or generate 0.0% return on investment in Palisade Bio over 180 days. Palisade Bio is related to or competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, Transcode Therapeutics, and Quoin Pharmaceuticals. Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing ... More
Palisade Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Palisade Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Palisade Bio upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 24.25 | |||
| Value At Risk | (8.55) | |||
| Potential Upside | 5.97 |
Palisade Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Palisade Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Palisade Bio's standard deviation. In reality, there are many statistical measures that can use Palisade Bio historical prices to predict the future Palisade Bio's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | 0.5256 |
Palisade Bio Backtested Returns
Palisade Bio maintains Sharpe Ratio (i.e., Efficiency) of -0.085, which implies the firm had a -0.085% return per unit of risk over the last 3 months. Palisade Bio exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Palisade Bio's Coefficient Of Variation of (1,011), risk adjusted performance of (0.07), and Variance of 23.86 to confirm the risk estimate we provide. The company holds a Beta of -0.94, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Palisade Bio are expected to decrease slowly. On the other hand, during market turmoil, Palisade Bio is expected to outperform it slightly. At this point, Palisade Bio has a negative expected return of -0.42%. Please make sure to check Palisade Bio's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Palisade Bio performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.80 |
Very good predictability
Palisade Bio has very good predictability. Overlapping area represents the amount of predictability between Palisade Bio time series from 26th of May 2024 to 24th of August 2024 and 24th of August 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Palisade Bio price movement. The serial correlation of 0.8 indicates that around 80.0% of current Palisade Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.8 | |
| Spearman Rank Test | 0.56 | |
| Residual Average | 0.0 | |
| Price Variance | 0.24 |
Palisade Bio lagged returns against current returns
Autocorrelation, which is Palisade Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Palisade Bio's stock expected returns. We can calculate the autocorrelation of Palisade Bio returns to help us make a trade decision. For example, suppose you find that Palisade Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Palisade Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Palisade Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Palisade Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Palisade Bio stock over time.
Current vs Lagged Prices |
| Timeline |
Palisade Bio Lagged Returns
When evaluating Palisade Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Palisade Bio stock have on its future price. Palisade Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Palisade Bio autocorrelation shows the relationship between Palisade Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Palisade Bio.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:Check out Palisade Bio Correlation, Palisade Bio Volatility and Palisade Bio Alpha and Beta module to complement your research on Palisade Bio. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Palisade Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.